
Medical cannabis accessible only via a complex special permit process through the State Agency of Medicines.
Medical cannabis is an unlicensed medicine in Estonia, accessible only through a special permit process. A specialist doctor applies on behalf of the patient to the Estonian State Agency of Medicines (SAM). If approved, the pharmacy acquires the product via a licensed wholesaler. The process is onerous and many pharmacies lack experience with cannabis.
Medical cannabis is an unlicensed medicine in Estonia and is only accessible through a special permit system administered by the Estonian State Agency of Medicines (SAM).
A specialist doctor must provide a medical justification demonstrating that other licensed treatment methods have been exhausted. The application is submitted via a pharmacy that holds a licence to handle narcotic substances.
SAM reviews the application and decides whether to grant a permit for the unlicensed product. If approved, the pharmacy orders from a wholesaler, which must obtain a separate import permit.
Who can prescribe: Specialist doctors, with justification that other treatments have been exhausted.
No formal list of approved conditions — access is via exceptional medical need only.
Reimbursement: No reimbursement framework.
Practical barriers: Many pharmacies and pharmaceutical wholesalers in Estonia have limited experience with cannabis, which can cause delays and complications throughout the supply chain.
No approved products are stocked in Estonian pharmacies. All access is via special permit and individual import per prescription.
Products are obtained through licensed pharmaceutical wholesalers on a case-by-case basis.
There is no formal import framework — imports are conducted on a per-permit basis via licensed wholesalers.
No domestic production industry exists in Estonia.





